News

Podimetrics Secures $45 Million Series C To Help At-Risk Providers and Health Plans Prevent Diabetic Amputations in High-Risk Patients, Keep Reading

Podimetrics Secures $45 Million Series C To Help At-Risk Providers and Health Plans Prevent Diabetic Amputations in High-Risk Patients, Keep Reading Read more…

Podimetrics Secures $45 Million Series C To Help At-Risk Providers and Health Plans Prevent Diabetic Amputations in High-Risk Patients, Keep Reading Read More »

Liberate Medical Reports Positive Pilot Trial Results of VentFree™ Respiratory Muscle Stimulator — Liberate Medical

Prof. Leo Heunks, MD, PhD, Amsterdam UMC, coordinating investigator for the study commented, “We’re very encouraged by these results, which indicate that the VentFree has the potential to meaningfully improve patient outcomes both during the COVID-19 pandemic and beyond.”  “We’re excited to announce these results” said Angus McLachlan, Liberate Medical Chief Executive Officer. “Reducing the

Liberate Medical Reports Positive Pilot Trial Results of VentFree™ Respiratory Muscle Stimulator — Liberate Medical Read More »